SLN

sarcolipin

Basic information

Region (hg38): 11:107707378-107719693

Links

ENSG00000170290NCBI:6588OMIM:602203HGNC:11089Uniprot:O00631AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLN gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
5
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 5 0 0

Variants in SLN

This is a list of pathogenic ClinVar variants found in the SLN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-107707858-G-T not specified Uncertain significance (Jan 10, 2023)2475286
11-107707866-A-G not specified Uncertain significance (Aug 28, 2023)2590379
11-107707878-G-A not specified Uncertain significance (Sep 22, 2023)3166161
11-107707893-G-A not specified Uncertain significance (Jun 28, 2024)3445735
11-107707914-C-T not specified Uncertain significance (Dec 11, 2024)3798757
11-107707923-A-G not specified Uncertain significance (Jul 12, 2023)2601305

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLNprotein_codingprotein_codingENST00000531293 112316
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2870.50100000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1891517.20.8729.44e-7197
Missense in Polyphen22.44860.8167823
Synonymous0.30067.010.8563.86e-764
Loss of Function0.23300.06340.002.60e-91

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Reversibly inhibits the activity of ATP2A1 in sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in muscle. Required for muscle-based, non-shivering thermogenesis (By similarity). {ECO:0000250|UniProtKB:Q9CQD6, ECO:0000269|PubMed:11781085, ECO:0000269|PubMed:9575189}.;
Pathway
Ion channel transport;Ion homeostasis;Transport of small molecules;Cardiac conduction;Muscle contraction;Ion transport by P-type ATPases (Consensus)

Intolerance Scores

loftool
rvis_EVS
0.08
rvis_percentile_EVS
59.43

Haploinsufficiency Scores

pHI
0.332
hipred
N
hipred_score
0.279
ghis
0.527

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianLowLowLow
Primary ImmunodeficiencyLowLowLow
CancerLowLowLow

Mouse Genome Informatics

Gene name
Sln
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
calcium ion transport;negative regulation of catalytic activity;negative regulation of protein complex disassembly;regulation of calcium ion transport;sarcoplasmic reticulum calcium ion transport;negative regulation of calcium ion import;positive regulation of cold-induced thermogenesis;negative regulation of calcium ion transmembrane transporter activity;regulation of relaxation of muscle;negative regulation of calcium ion binding;positive regulation of protein depolymerization;regulation of calcium-transporting ATPase activity
Cellular component
integral component of membrane;sarcoplasmic reticulum;sarcoplasmic reticulum membrane
Molecular function
enzyme inhibitor activity;protein binding;ATPase binding